Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Vaxcyte to Present at the Guggenheim Emerging Outlook: Biotech Summit
-
Fortinet Reports Strong Fourth Quarter and Full Year 2025 Financial Results
-
Georgia School of Orthodontics Appoints Dr. Mohamed I. Masoud as Director of Research to Advance Academic Innovation, Community Impact
-
Synaptics Reports Second Quarter Fiscal 2026 Results
-
Amwell® to report fourth quarter and full year 2025 operating results
-
Talkspace to Report Fourth Quarter and Full Year 2025 Results and Host Conference Call
-
IBEX Reports Record Quarterly Revenue and EPS, Raises Fiscal Year Guidance
-
Flowserve Expands Leadership in Nuclear and Other Power End Markets with Strategic Acquisition of Trillium Flow Technologies’ Valves Division
-
Phillips Edison & Company Reports Fourth Quarter and Full Year 2025 Results
-
Exponent Increases Quarterly Dividend Payment from $0.30 to $0.31 per Share for Q1 2026
-
Exponent Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026
-
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
-
Hippo to Report Fourth Quarter Financial Results on February 25, 2026
-
LiveRamp Announces Results for Third Quarter FY26
-
Gold.com Reports Fiscal Second Quarter 2026 Results
-
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March
-
StepStone Group Reports Third Quarter Fiscal Year 2026 Results
-
Paylocity Announces Second Quarter Fiscal Year 2026 Financial Results
-
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update
-
ServiceTitan to Announce Fiscal Fourth Quarter and Full Year Fiscal 2026 Financial Results on March 12, 2026
-
TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares
-
Nutanix Announces Date and Conference Call Information for Second Quarter Fiscal Year 2026 Financial Results
-
Baker Hughes Declares Quarterly Dividend
-
The Uptown Agency Becomes LIVV Audio's Agency of Record
-
IREN Reports Q2 FY26 Results
-
Ribbon Communications Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
-
Lulus Appoints Heidi Crane as Permanent Chief Financial Officer
-
Everest Medicines Announces Exclusive License Agreement with Micot to Commercialize MT1013
-
Warner Music Group Corp. Reports Results for Fiscal First Quarter Ended December 31, 2025
-
Atlassian Announces Second Quarter Fiscal Year 2026 Results
-
Franklin Street Properties Corp. Provides Additional Update on Review of Strategic Alternatives
-
Monolithic Power Systems Announces CFO Transition
-
Landmark Study Finds Promotional Products Deliver High Brand Recall With Lower Carbon Impact Than Most Advertising
-
Magnolia Oil & Gas Corporation Announces 2025 Fourth Quarter and Year End Results
-
BILL Reports Second Quarter Fiscal Year 2026 Financial Results
-
Power Integrations Reports Fourth-Quarter and Full-Year Financial Results
-
Triad Business Bank (OTCID – “TBBC”), February 5, 2026, Announces Unaudited Results for 2025, Including Fourth Quarter Results
-
Amazon.com Announces Fourth Quarter Results
-
Arrow Electronics Reports Fourth-Quarter and Full-Year 2025 Results
-
OpenText Reports Second Quarter Fiscal Year 2026 Financial Results
-
Doximity Announces Fiscal 2026 Third Quarter Financial Results
-
Alpha and Omega Semiconductor Reports Financial Results for the Fiscal Second Quarter of 2026 Ended December 31, 2025
-
Monolithic Power Systems Provides Earnings Commentary for the Quarter and Year Ended December 31, 2025
-
Monolithic Power Systems Announces Results for the Fourth Quarter and Year Ended December 31, 2025 and an Increase in Quarterly Cash Dividend
-
Los Angeles Orthopedic Surgeon Expands Minimally Invasive Hip Replacement Options with Bikini Incision Direct Anterior Approach
-
McGrath Announces Chief Executive Officer Succession
-
Silvercrest Asset Management Group Inc. Announces Quarterly Dividend
-
Nerdy to Announce Fourth Quarter and Full Year 2025 Results on February 26, 2026
-
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
